Lifevantage

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Lifevantage and other ETFs, options, and stocks.

About LFVN

LifeVantage Corp. engages in the identification, research, development, formulation, and sale of nutraceutical dietary supplements and personal care products. Its products include Protandim, Axio, TrueScience, PhysIQ, and Petandim. 

CEO
Steven R. Fife
CEOSteven R. Fife
Employees
238
Employees238
Headquarters
Lehi, Utah
HeadquartersLehi, Utah
Founded
1988
Founded1988
Employees
238
Employees238

LFVN Key Statistics

Market cap
81.29M
Market cap81.29M
Price-Earnings ratio
8.23
Price-Earnings ratio8.23
Dividend yield
2.76%
Dividend yield2.76%
Average volume
160.36K
Average volume160.36K
High today
$6.40
High today$6.40
Low today
$6.20
Low today$6.20
Open price
$6.29
Open price$6.29
Volume
19.07K
Volume19.07K
52 Week high
$25.89
52 Week high$25.89
52 Week low
$5.69
52 Week low$5.69

Stock Snapshot

With a market cap of 81.29M, Lifevantage(LFVN) trades at $6.40. The stock has a price-to-earnings ratio of 8.23 and currently yields dividends of 2.8%.

As of 2026-01-20, Lifevantage(LFVN) stock has fluctuated between $6.20 and $6.40. The current price stands at $6.40, placing the stock +3.2% above today's low and 0.0% off the high.

The Lifevantage(LFVN)'s current trading volume is 19.07K, compared to an average daily volume of 160.36K.

In the last year, Lifevantage(LFVN) shares hit a 52-week high of $25.89 and a 52-week low of $5.69.

In the last year, Lifevantage(LFVN) shares hit a 52-week high of $25.89 and a 52-week low of $5.69.

People also own

Based on the portfolios of people who own LFVN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .